Previous Hold Today AIMT ranks #2071 as HOLD CANDIDATE #2071 Next Hold

AIMT stock forecast Aimmune Therapeutics

AIMT stock forecast

Friday January 17, 2020 Change -4.49% Price $34.92
Your prediction: Prediction: Request
VOLUME
Buy
TREND
Buy
MV LONG
Buy

MV SHORT
Buy

PIVOT
Sell

MACD
Sell
Bullish vs. Bearish (175 opinions)
74%
26%
Social Sentiment 0.03

AIMT Forecast and Technical Stock Analysis


Hold candidate since 2020-01-17 PDF

Aimmune Therapeutics fell by -4.49% in the last day ( Friday, 17th Jan 2020 ) from $36.56 to $34.92 During the day the stock fluctuated 9.29% from a day low at $33.68 to a day high of $36.80. The price has fallen in 7 of the last 10 days and is down by -0.48% for this period. Volume has increased in the last day by 0.65 million shares but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 1.79 million shares bought and sold for approximately $62.58 million.

Quick summary:

  • 30 day high of the AIMT stock price was $37.00 and low was $30.02.
  • 90 day high was $37.00 and low was $25.20.
  • 52 week high for Aimmune Therapeutics - $37.00 and low - $16.95.
Top Trending Stocks

Trend

Aimmune Therapeutics lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 31.73% during the next 3 months and, with 90% probability hold a price between $41.27 and $48.35 at the end of this period.

Top Golden Star Stocks

Signals

Aimmune Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $33.64 and $32.02. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Thursday January 16, 2020, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 58 and the stock is currently not being overbought or oversold

* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $31.40 and $28.06.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Aimmune Therapeutics finds support just below today's level at $31.40. If this is broken, then the next support from accumulated volume will be at $28.06 and $26.47.

Support: $31.40 Price: $34.92 Resistance: $35.00

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $3.13 between high and low, or 9.29%. For the last week, the stock has had a daily average volatility of 7.68%.

Our recommended stop-loss: $33.13 (-5.13%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from pivot top found 1 day(s) ago.)

7.68 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Hold/Accumulate Downgraded

Evaluation

Aimmune Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since last evaluation from a Strong Buy Candidate to a Hold/Accumulate candidate.

The general sentiment holds a neutral evaluation of the stock right now. The sentiment is based upon 175 votes on StockTwits.

Previous Hold Today AIMT ranks #2071 as HOLD CANDIDATE #2071 Next Hold
Exchange: NASDAQ | NYSE | XLON | AMS | TSX | BRU

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

Proudly Made At

ROCKIT